240 related articles for article (PubMed ID: 32505995)
41. A comparison of spray drying and milling in the production of amorphous dispersions of sulfathiazole/polyvinylpyrrolidone and sulfadimidine/polyvinylpyrrolidone.
Caron V; Tajber L; Corrigan OI; Healy AM
Mol Pharm; 2011 Apr; 8(2):532-42. PubMed ID: 21323367
[TBL] [Abstract][Full Text] [Related]
42. Multifunctional poly(D,L-lactide-co-glycolide)/montmorillonite (PLGA/MMT) nanoparticles decorated by Trastuzumab for targeted chemotherapy of breast cancer.
Sun B; Ranganathan B; Feng SS
Biomaterials; 2008 Feb; 29(4):475-86. PubMed ID: 17953985
[TBL] [Abstract][Full Text] [Related]
43. Drug release characteristics from nanoclay hybrids and their dispersions in organic polymers.
Ha JU; Xanthos M
Int J Pharm; 2011 Jul; 414(1-2):321-31. PubMed ID: 21601624
[TBL] [Abstract][Full Text] [Related]
44. To enhance dissolution rate of poorly water-soluble drugs: glucosamine hydrochloride as a potential carrier in solid dispersion formulations.
Al-Hamidi H; Edwards AA; Mohammad MA; Nokhodchi A
Colloids Surf B Biointerfaces; 2010 Mar; 76(1):170-8. PubMed ID: 19945828
[TBL] [Abstract][Full Text] [Related]
45. Effects of chitosan molecular weight on the physical and dissolution characteristics of amorphous curcumin-chitosan nanoparticle complex.
Yu H; Nguyen MH; Hadinoto K
Drug Dev Ind Pharm; 2018 Jan; 44(1):82-88. PubMed ID: 28849675
[TBL] [Abstract][Full Text] [Related]
46. Lipid- and Polymer-Based Nanostructures for Cutaneous Delivery of Curcumin.
Caon T; Mazzarino L; Simões CM; Senna EL; Silva MA
AAPS PharmSciTech; 2017 Apr; 18(3):920-925. PubMed ID: 27230504
[TBL] [Abstract][Full Text] [Related]
47. Use of surfactants as plasticizers in preparing solid dispersions of poorly soluble API: selection of polymer-surfactant combinations using solubility parameters and testing the processability.
Ghebremeskel AN; Vemavarapu C; Lodaya M
Int J Pharm; 2007 Jan; 328(2):119-29. PubMed ID: 16968659
[TBL] [Abstract][Full Text] [Related]
48. Efavirenz Dissolution Enhancement IV-Antisolvent Nanocrystallization by Sonication, Physical Stability, and Dissolution.
Sartori GJ; Prado LD; Rocha HVA
AAPS PharmSciTech; 2017 Nov; 18(8):3011-3020. PubMed ID: 28493004
[TBL] [Abstract][Full Text] [Related]
49. Production of nano-solid dispersions using a novel solvent-controlled precipitation process - Benchmarking their in vivo performance with an amorphous micro-sized solid dispersion produced by spray drying.
Duarte Í; Corvo ML; Serôdio P; Vicente J; Pinto JF; Temtem M
Eur J Pharm Sci; 2016 Oct; 93():203-14. PubMed ID: 27519665
[TBL] [Abstract][Full Text] [Related]
50. Different BCS Class II Drug-Gelucire Solid Dispersions Prepared by Spray Congealing: Evaluation of Solid State Properties and In Vitro Performances.
Bertoni S; Albertini B; Passerini N
Pharmaceutics; 2020 Jun; 12(6):. PubMed ID: 32545643
[TBL] [Abstract][Full Text] [Related]
51. Inorganic matrices: an answer to low drug solubility problem.
Perioli L; Pagano C
Expert Opin Drug Deliv; 2012 Dec; 9(12):1559-72. PubMed ID: 23061519
[TBL] [Abstract][Full Text] [Related]
52. Salt-kneading: alternative sizing of active pharmaceutical ingredients?
Šimek M; Vyňuchal J; Tomášová L
Pharm Dev Technol; 2016 Dec; 21(8):972-979. PubMed ID: 26365246
[TBL] [Abstract][Full Text] [Related]
53. Fast drying of biocompatible polymer films loaded with poorly water-soluble drug nano-particles via low temperature forced convection.
Susarla R; Sievens-Figueroa L; Bhakay A; Shen Y; Jerez-Rozo JI; Engen W; Khusid B; Bilgili E; Romañach RJ; Morris KR; Michniak-Kohn B; Davé RN
Int J Pharm; 2013 Oct; 455(1-2):93-103. PubMed ID: 23911341
[TBL] [Abstract][Full Text] [Related]
54. Critical material attributes (CMAs) of strip films loaded with poorly water-soluble drug nanoparticles: III. Impact of drug nanoparticle loading.
Krull SM; Moreno J; Li M; Bilgili E; Davé RN
Int J Pharm; 2017 May; 523(1):33-41. PubMed ID: 28315716
[TBL] [Abstract][Full Text] [Related]
55. Fabrication of a Soybean Bowman-Birk Inhibitor (BBI) Nanodelivery Carrier To Improve Bioavailability of Curcumin.
Liu C; Cheng F; Yang X
J Agric Food Chem; 2017 Mar; 65(11):2426-2434. PubMed ID: 28249113
[TBL] [Abstract][Full Text] [Related]
56. Modulation of particle size and molecular interactions by sonoprecipitation method for enhancing dissolution rate of poorly water-soluble drug.
Tran TT; Tran KA; Tran PH
Ultrason Sonochem; 2015 May; 24():256-63. PubMed ID: 25500098
[TBL] [Abstract][Full Text] [Related]
57. Polyelectrolyte Complex Nanoparticles from Chitosan and Acylated Rapeseed Cruciferin Protein for Curcumin Delivery.
Wang F; Yang Y; Ju X; Udenigwe CC; He R
J Agric Food Chem; 2018 Mar; 66(11):2685-2693. PubMed ID: 29451796
[TBL] [Abstract][Full Text] [Related]
58. Octenylsuccinate hydroxypropyl phytoglycogen, a dendrimer-like biopolymer, solubilizes poorly water-soluble active pharmaceutical ingredients.
Xie Y; Yao Y
Carbohydr Polym; 2018 Jan; 180():29-37. PubMed ID: 29103508
[TBL] [Abstract][Full Text] [Related]
59. Improved properties of fine active pharmaceutical ingredient powder blends and tablets at high drug loading via dry particle coating.
Kunnath K; Huang Z; Chen L; Zheng K; Davé R
Int J Pharm; 2018 May; 543(1-2):288-299. PubMed ID: 29625168
[TBL] [Abstract][Full Text] [Related]
60. Hybrid nanocrystal-amorphous solid dispersions (HyNASDs) as alternative to ASDs for enhanced release of BCS Class II drugs.
Rahman M; Arevalo F; Coelho A; Bilgili E
Eur J Pharm Biopharm; 2019 Dec; 145():12-26. PubMed ID: 31622652
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
